Table 1 Demographic data of 233 patients with non-massive hemoptysis
From: Feasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysis
Characteristic | Value (N = 233) |
|---|---|
Age (years) | 56.9 ± 14.8 |
Sex (male/female) | 143/90 |
Underlying disease | |
DM/HTN | 17/34 |
Causes of non-massive hemoptysis | |
TB sequelae | 99 (42.5) |
Bronchiectasis | 31 (13.2) |
Tuberculosis destroyed lung | 25 (10.9) |
Aspergilloma | 26 (11.1) |
Fibrotic scar change | 17 (7.3) |
Active TB | 31 (13.2) |
Mycobacterium tuberculosis | 28 (11.9) |
Multidrug-resistant tuberculosis | 3 (1.3) |
Nontuberculous mycobacteria | 8 (3.3) |
Bronchiectasis without TB | 35 (15.2) |
Pneumonia | 27 (11.6) |
Lung cancer | 11 (4.6) |
Others | 22 (9.6) |
Amount of hemoptysis (mL) | |
< 50 | 92 (39.5) |
50–100 | 81 (34.7) |
101–200 | 57 (24.5) |
201–300 | 3 (1.3) |
Pre-procedural evaluationa | |
Contrast-enhanced CT + Bronchoscopy | 147 (63.1%) |
Contrast-enhanced CT | 72 (31.0%) |
Bronchoscopy | 3 (1.2%) |
None | 11 (4.7%) |
In-hospital mortality | |
Yesb | 5 (2.1) |
No | 228 (97.9) |